Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Cash Flows

v3.21.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 55,900 $ 213
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Amortization And Non-Cash Lease Expense 30,459 32,994
Accounts Receivable, Credit Loss Expense (Reversal) (7,849) 19,229
Loss on disposal or impairment of property, plant, and equipment 131 2,138
Deferred income taxes 4,577 3,802
Share-based Payment Arrangement, Noncash Expense 4,874 3,675
Changes in operating assets and liabilities:    
Increase (Decrease) in Accounts Receivable 117,818 150,687
Increase (Decrease) in Inventories 25,117 23,510
Increase (Decrease) in Prepaid Expense and Other Assets (11,150) (11,922)
Increase (Decrease) in Other Operating Assets 51 (5,873)
Increase (Decrease) in Accounts Payable (41,194) (100,402)
Increase (Decrease) in Accrued Liabilities (27,253) (77,861)
Increase (Decrease) in Income Taxes Payable (19,291) (9,429)
Increase (Decrease) In Operating Lease, Right-Of-Use Assets And Liabilities (21,273) (16,807)
Other liabilities (18) (1,200)
Net cash provided by operating activities 110,899 12,754
Cash flows from investing activities:    
Payments to Acquire Short-term Investments 0 (35,044)
Proceeds from Sale, Maturity and Collection of Short-term Investments 1,054 1,631
Payments to Acquire Property, Plant, and Equipment (3,896) (9,452)
Net cash used in investing activities (2,842) (42,865)
Cash flows from financing activities:    
Proceeds from Lines of Credit 7,753 175,719
Repayments of Lines of Credit (7,532) (1,054)
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 13,772 1,096
Payment, Tax Withholding, Share-based Payment Arrangement (5,358) (4,207)
Payments for Repurchase of Common Stock (11,223) (132,889)
Payments of Ordinary Dividends, Common Stock (17,285) (17,195)
Net cash used in financing activities (19,873) 21,470
Effect of Exchange Rate on Cash and Cash Equivalents (5,268) (6,260)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total 82,916 (14,901)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning Balance 790,725 686,009
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 873,641 671,108
Supplemental disclosures of cash flow information:    
Income Taxes Paid 37,534 19,953
Supplemental disclosures of non-cash investing activities:    
Capital expenditures incurred but not yet paid $ 2,832 $ 2,503